Chad J. Kolean - 22 Feb 2022 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Financial Officer
Signature
/s/ Asher M. Rubin, Attorneyin-fact for Chad Kolean
Issuer symbol
CLRB
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
4
Filing time
24 Feb 2022, 16:00:59 UTC
Next filing
15 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +150,000 $0.000000 150,000 22 Feb 2022 Common Stock 150,000 $0.4900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant.